Rupert Leong

Rupert Leong is a Clinical Professor of Medicine at the University of Sydney and Macquarie University, and Director of Endoscopy at Concord Hospital. He specializes in gastroenterology, particularly inflammatory bowel disease (IBD), colorectal cancer surveillance, and endoscopy. His roles include leading the Inflammatory Bowel Disease Services at Concord Hospital and serving as a founding director of IBD Sydney. He holds academic titles including FRACP and AGAF, and has contributed to national and international consensus guidelines on IBD and colorectal cancer prevention.

Leong's research focuses on gastroenterology, immunology, and biomarkers, with over 200 peer-reviewed publications. He is an editorial board member for journals like Alimentary Pharmacology and Therapeutics and Gastrointestinal Endoscopy. His honors include the American Gastroenterological Association Fellowship (2012) and UNSW Paper of the Year (2015).

Key research interests include intestinal permeability, dysplasia, and endoscopic imaging innovations. His work emphasizes translational medicine, linking clinical care with microbiome research and advanced therapies for IBD. Collaborations include international projects with the Chinese University of Hong Kong.

• Education: MBBS, FRACP, MD
• Grants: NHMRC CD Fellowship, UNSW Faculty Research Grants
• Leadership: Agency for Clinical Innovation (NSW Health), Cancer Council Australia Working Party
• Teams: Leads the Australian IBD Microbiome (AIM) Study and the Persistence Australian National IBD Cohort (PANIC) registry.